Skip to main content
TipRanks
Go Ultimate75% OFF

Recursion Pharmaceuticals (RXRX) Q4 2025 Earnings Report

4,728 Followers

RXRX Q4 2025 EPS Results

Actual EPS
-$0.21
Consensus EPS
-$0.30
Beat/Miss
Beat by +$0.09
One Year Ago EPS
-$0.53

RXRX Q4 2025 Revenue Results

Actual Revenue
$35.54M
Expected Revenue
$24.54M
Beat/Miss
Beat by +$10.99M
YoY Revenue Growth
+681.74%

Earnings Announcement Details

Quarter
Q4 2025
Date
02/25/2026
Time
Before Open
Conference Call
Wednesday, February 25, 2026
RXRX Upcoming Earnings

Recursion Pharmaceuticals's next earnings date is estimated for March 3, 2027, based on past reporting schedules.

Q4 2025 Earnings Call Audio

RXRX Q4 2025 Earnings Call
0:00 / 0:00

Q4 2025 Earnings Slide Deck

Q4 2025 Earnings Call Summary

No earnings call summary is available for this earnings event.

RXRX Earnings History

RXRX earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 03, 20272026 (Q4)-0.20--0.21――
Nov 02, 20262026 (Q3)-0.22-0.22-0.3638.89% (+0.14)
Aug 05, 20262026 (Q2)-0.24-0.25-0.4139.02% (+0.16)
May 06, 20262026 (Q1)-0.27-0.22-0.556.00% (+0.28)
Feb 25, 20262025 (Q4)-0.30-0.21-0.5360.38% (+0.32)
Nov 05, 20252025 (Q3)-0.38-0.36-0.34-5.88% (-0.02)
Aug 05, 20252025 (Q2)-0.35-0.41-0.4-2.50% (-0.01)
May 05, 20252025 (Q1)-0.52-0.50-0.39-28.21% (-0.11)
Feb 28, 20252024 (Q4)-0.41-0.53-0.42-26.19% (-0.11)
Nov 06, 20242024 (Q3)-0.33-0.34-0.4320.93% (+0.09)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed